3 most recent filings and news items mentioning CING. Updated every 60 seconds.
curl "https://api.brieftape.com/v1/tickers/CING/news?limit=20"
Pull CING filings straight into your trading bot, model, or app.
Get an API key — free tier: 10,000 calls/dayCingulate Inc. announced the issuance of U.S. Patent No. 12,653,791 for its lead ADHD asset CTx-1301, protecting the drug's formulation and method of use through December 2042. The patent strengthens the company's intellectual property portfolio as it advances toward potential co
View filing at SEC.gov →Apple To Rally More Than 19%? Here Are 10 Top Analyst Forecasts For Tuesday
View filing at SEC.gov →Cingulate received an FDA Complete Response Letter for its ADHD drug CTx-1301 with only Chemistry, Manufacturing and Controls (CMC) information requests and no clinical safety or efficacy concerns identified. The company has $30 million in cash and plans to promptly resubmit with
View filing at SEC.gov →